Cargando…

Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa

Recent advancements in the field of in vitro transcribed mRNA (IVT-mRNA) vaccination have attracted considerable attention to such vaccination as a cutting-edge technique against infectious diseases including COVID-19 caused by SARS-CoV-2. While numerous pathogens infect the host through the respira...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Jie, Cai, Larry, Xu, Chuanfei, Sun, Si, Liu, Yuheng, Rosenecker, Joseph, Guan, Shan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777913/ https://www.ncbi.nlm.nih.gov/pubmed/35055244 http://dx.doi.org/10.3390/nano12020226

Ejemplares similares

In Vitro Investigations on Optimizing and Nebulization of IVT-mRNA Formulations for Potential Pulmonary-Based Alpha-1-Antitrypsin Deficiency Treatment †
por: Guan, Shan, et al.
Publicado: (2021)

Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration
por: Johler, Sarah M., et al.
Publicado: (2015)

Recent Advances and Innovations in the Preparation and Purification of In Vitro-Transcribed-mRNA-Based Molecules
por: Zhang, Jingjing, et al.
Publicado: (2023)

Visualization and Estimation of Nasal Spray Delivery to Olfactory Mucosa in an Image-Based Transparent Nasal Model
por: Seifelnasr, Amr, et al.
Publicado: (2023)

Nanotechnology in vaccine delivery()
por: Peek, Laura J., et al.
Publicado: (2008)

Role of nanotechnology behind the success of mRNA vaccines for COVID-19
por: Khurana, Amit, et al.
Publicado: (2021)

Nanotechnology and pulmonary delivery to overcome resistance in infectious diseases()
por: Andrade, Fernanda, et al.
Publicado: (2013)

Mechanisms allowing protein delivery in nasal mucosa using NPL nanoparticles
por: Bernocchi, B., et al.
Publicado: (2016)

Fibrinolytic components in nasal mucosa and nasal secretion
por: Yasuda, Toyotoshi, et al.
Publicado: (1998)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge
por: Sun, Si, et al.
Publicado: (2023)

The Relation of the Nasal Mucosa to the Genitals
por: Robinson, Byron
Publicado: (1897)

HDAC inhibitor sodium butyrate prevents allergic rhinitis and alters lncRNA and mRNA expression profiles in the nasal mucosa of mice
por: Wang, Jie, et al.
Publicado: (2020)

Delivery Strategies for mRNA Vaccines
por: Ramachandran, Sivakumar, et al.
Publicado: (2022)

The Delivery of mRNA Vaccines for Therapeutics
por: Nitika,, et al.
Publicado: (2022)

Relative vascular permeability and vascularity across different regions of the rat nasal mucosa: implications for nasal physiology and drug delivery
por: Kumar, Niyanta N., et al.
Publicado: (2016)

Nanotechnology in pulmonary medicine
por: Doroudian, Mohammad, et al.
Publicado: (2021)

Identification of pannexins in rat nasal mucosa
por: Ohbuchi, Toyoaki, et al.
Publicado: (2013)

Aminopeptidase activity in human nasal mucosa()()()()
por: Ohkubo, Kimihiro, et al.
Publicado: (1998)

Use of nasal mucosa graft in tympanoplasty
por: Coelho, Sandro Barros, et al.
Publicado: (2020)

Nanotechnology in Advanced Drug Delivery
por: Jain, Sanyog, et al.
Publicado: (2011)

Delivery of nutraceuticals using nanotechnology
por: Wiwanitkit, Viroj
Publicado: (2012)

Nanotechnological Strategies for Protein Delivery
por: Villegas, María Rocío, et al.
Publicado: (2018)

Nanotechnological approaches for pentamidine delivery
por: Andreana, Ilaria, et al.
Publicado: (2022)

Nanotechnology in drug and gene delivery
por: Hamimed, Selma, et al.
Publicado: (2022)

Nanotechnology in Targeted Drug Delivery
por: Di Stefano, Antonio
Publicado: (2023)

Application of nanotechnology in drug delivery systems for respiratory diseases
por: Luo, Ming-Xin, et al.
Publicado: (2021)

Yeasts in nanotechnology-enabled oral vaccine and gene delivery
por: Ivanova, Elena
Publicado: (2021)

Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV
por: Lindsay, Kevin E., et al.
Publicado: (2020)

Structural DNA nanotechnology
por: Seeman, Nadrian C
Publicado: (2015)

Clinical approval of nanotechnology-based SARS-CoV-2 mRNA vaccines: impact on translational nanomedicine
por: Milane, Lara, et al.
Publicado: (2021)

From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines
por: Lopez-Cantu, Diana O., et al.
Publicado: (2022)

mRNA vaccines: A matter of delivery
por: Cao, Yuhong, et al.
Publicado: (2021)

Development and Delivery Systems of mRNA Vaccines
por: Liang, Yongjun, et al.
Publicado: (2021)

Nanomaterial Delivery Systems for mRNA Vaccines
por: Buschmann, Michael D., et al.
Publicado: (2021)

The expression analysis of IL-6, IL-18, IL-21, IL-23, and TGF-β mRNA in the nasal mucosa of patients with Allergic rhinitis
por: Mirzaei, Yousef, et al.
Publicado: (2022)

Expansion of cytotoxic tissue-resident CD8(+) T cells and CCR6(+)CD161(+) CD4(+) T cells in the nasal mucosa following mRNA COVID-19 vaccination
por: Ssemaganda, Aloysious, et al.
Publicado: (2022)

A laser device for fusion of nasal mucosa
por: Larson, Michael, et al.
Publicado: (2010)

The effects of intermittent hypoxia on human nasal mucosa
por: In, Seung Min, et al.
Publicado: (2021)

Nasal Vaccine Delivery
por: Ramvikas, M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ner2j4et2jvb88lcb15rt02h06